Allgens Medical Technology Co. Ltd.
Shanghai Stock ExchangeTotal Valuation
Allgens Medical Technology Co. Ltd. carries a market capitalization of 2.02B, placing it among publicly traded companies globally. Its enterprise value stands at 995.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.02B |
| Enterprise Value | 995.73M |
Share Statistics
Allgens Medical Technology Co. Ltd. currently has 137.01M shares outstanding.
| Shares Outstanding | 137.01M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Allgens Medical Technology Co. Ltd. trades at a trailing price-to-earnings ratio of 112.65. The price-to-sales ratio is 9.67, and the price-to-book ratio stands at 4.99.
| PE Ratio | 112.65 |
| PS Ratio | 9.67 |
| PB Ratio | 4.99 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | 116.63 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 4.84 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 50.04 |
Financial Position
Allgens Medical Technology Co. Ltd. maintains a current ratio of 14.33, meaning it holds 14.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.23, indicating elevated leverage, while an interest coverage ratio of -12.61 demonstrates limited ability to service its debt obligations.
| Current Ratio | 14.33 |
| Quick Ratio | 12.33 |
| Debt / Equity | 3.23 |
| Debt / EBITDA | -2.54 |
| Interest Coverage | -12.61 |
Financial Efficiency
| Return on Equity (ROE) | -3.39 |
| Return on Assets (ROA) | -0.89 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 0.03 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.12 |
Taxes
Over the trailing twelve months, Allgens Medical Technology Co. Ltd. has paid 8.03M in income taxes, reflecting an effective tax rate of 536.26.
| Income Tax | 8.03M |
| Effective Tax Rate | 536.26 |
Stock Price Statistics
Allgens Medical Technology Co. Ltd.'s stock has declined approximately -18.94273% over the past 52 weeks. The 50-day moving average sits at 17.57, while the 200-day moving average is 21.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.94273% |
| 50-Day Moving Average | 17.57 |
| 200-Day Moving Average | 21.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Allgens Medical Technology Co. Ltd. generated 205.83M in revenue and converted that into -13.91M in net income, yielding earnings per share of -0.16. EBITDA reached -18.35M, while operating income came in at -18.35M.
| Revenue | 205.83M |
| Gross Profit | 132.65M |
| Operating Income | -18.35M |
| Pretax Income | -8.51M |
| Net Income | -13.91M |
| EBITDA | -18.35M |
| EBIT | -18.35M |
| Earnings Per Share (EPS) | -0.16 |
Balance Sheet
Allgens Medical Technology Co. Ltd. holds 1.06B in cash and equivalents against 46.60M in total debt, resulting in a net debt position of -139.62M. Total book value stands at 399.12M, with working capital of 1.14B providing operational flexibility.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 46.60M |
| Net Debt | -139.62M |
| Equity (Book Value) | 399.12M |
| Book Value Per Share | 3.83 |
| Working Capital | 1.14B |
Cash Flow
After subtracting -17.07M in capital expenditures, free cash flow totaled -17.07M - equivalent to -0.16 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -17.07M |
| Free Cash Flow | -17.07M |
| FCF Per Share | -0.16 |
Margins
Allgens Medical Technology Co. Ltd. operates with a gross margin of 64.45, reflecting its pricing power and cost economics. The operating margin of -8.91 and net profit margin of -6.76 provide insight into operational efficiency.
| Gross Margin | 64.45 |
| Operating Margin | -8.91 |
| Pretax Margin | -4.14 |
| Profit Margin | -6.76 |
| EBITDA Margin | -8.91 |
Dividends & Yields
The company's payout ratio of -53.31 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.10 |
| Dividend Yield | N/A |
| Payout Ratio | -53.31 |
| Shareholder Yield | 0.44 |
| FCF Yield | 0.86 |
Scores
Allgens Medical Technology Co. Ltd. posts an Altman Z-Score of 11.46, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.46 |